• Biomarkers

    Biomarkers are quantifiable indicators of physiological or pathological processes in the body. They can be useful in establishing a diagnosis, assessing disease progression and a patient's condition and guide therapeutic interventions. However, a great deal could still be done to further improve the utilisation of biomarkers in critical care....

    READ MORE
  • Biomarkers for ARDS. What is New?

    Despite several biomarkers having been studied for diagnosis and/or prognosis of acute respiratory distress syndrome (ARDS), their extensive use has not been established. Better knowledge of the pathophysiology of ARDS and acute lung injury (ALI) may help develop new biomarkers. Acute respiratory distress syndrome (ARDS) is characterised by...

    READ MORE
  • Biomarkers in Sepsis

    This article describes the application of existing and emerging biomarkers in the diagnosis and management of sepsis and pneumonia. Introduction: The Need for  Biomarkers  in Sepsis Sepsis is defined as a dysregulated host response to infection that results in life threatening organ dysfunction. It carries an estimated...

    READ MORE
  • Biomarkers of Infection in the Intensive Care Unit

    Biomarkers are an area of rapid discovery in critical care medicine today. They have the potential to improve our ability to identify and manage patients at increased risk of organ failure and death. This article provides an overview of biomarkers of infection in the intensive care unit. The heterogeneity of sepsis makes its identification...

    READ MORE
  • Utility of Biomarkers in Obstetric Patients With Preeclampsia

    Preeclampsia is a complex syndrome whose complications bear an impact on perinatal morbidity and mortality. Angiogenic biomarkers may significantly impact both the decision to admit patients and risk stratification and may also help guide patient management and level of care. Preeclampsia is one of the main causes of maternal and foetal morbimortality,...

    READ MORE
  • Sepsis Diagnosis: Clinical Signs, Scores, and Biomarkers

    Abstract     Sepsis and antimicrobial resistance are two major public health problems . Sepsis is defined as a dysregulated response of the body to a bacterial infection with organ dysfunction . The 2021 Surviving Sepsis Campaign SSC guidelines proposed characterising the infection based on clinical assessment and the dysregulated...

    READ MORE
  • Sepsis Diagnosis: Pancreatic Stone Protein in Adults, Children, and Neonates

    Based on the concepts and the checklist criteria for an ideal sepsis biomarker presented in the article Sepsis Diagnosis: Clinical signs, Scores, and Biomarkers in this issue of ICU Management & Practice , we update and review the potential use of Pancreatic Stone Protein (PSP) in adults, children, and neonates.     Pancreatic Stone...

    READ MORE
  • Tachycardia in Sepsis: Friend or Foe?

    An overview of tachycardia in sepsis, the importance of rate control and the beneficial effects of beta-blockers.         Sepsis and Tachycardia – Aetiologic Factors During sepsis, the sympathetic nervous system plays a key role in maintaining cardiac output and blood pressure. This is achieved through changes...

    READ MORE
  • The Role of the Paediatrician in the Coordination Centre

    Since 2017, the Medical Emergency System of Catalonia has included a paediatrician specialised in critical care at its coordination centre. Their duties are to manage the coordination of interhospital transfers and provide telephone support for paediatric and neonatal emergencies. Here we present our experience and the challenges that we have encountered....

    READ MORE
  • Upcoming events/courses/congresses

    MARCH   21-24 42nd ISICEM Brussels, Belgium https://iii.hm/1jog   APRIL   4 ICU Management & Practice DigiConf Biomarkers Virtual Event https://iii.hm/1joi   15-18 33rd ECCMID Copenhagen, Denmark https://iii.hm/1joj   20-22 NATA 23rd Annual Symposium Athens, Greece https://iii.hm/1jok...

    READ MORE
Subscribe To The ICU Management Channel